Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Gastrointestinal Cancer Excellence Forum

Gastrointestinal Cancer
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Dr King Highlights Progress of Ongoing Feasibility Study for Biliary Tract Cancer
Videos
Dr King Highlights Progress of Ongoing Feasibility Study for Biliary Tract Cancer
01/26/2021
Gentry King, MD, discusses an ongoing feasibility study on multiomic platform-based testing in patients with localized and resectable biliary tract cancers.
Gentry King, MD, discusses an ongoing feasibility study on multiomic platform-based testing in patients with localized and resectable biliary tract cancers.
Gentry King, MD, discusses an...
01/26/2021
Oncology
Andres Cervantes, MD, PhD, Discusses Trastuzamab Deruxtecan as Emerging Therapy for Gastric Cancer
Podcasts
Andres Cervantes, MD, PhD, Discusses Trastuzamab Deruxtecan as Emerging Therapy for Gastric Cancer
01/19/2021
Dr Cervantes highlights the significance of the DESTINY-Gastric01 trial and discusses new advancements in the treatment of HER2+ gastric cancer.
Dr Cervantes highlights the significance of the DESTINY-Gastric01 trial and discusses new advancements in the treatment of HER2+ gastric cancer.
Dr Cervantes highlights the...
01/19/2021
Oncology
Katrina Pedersen, MD, MS, Provides an Overview of Small Bowel Adenocarcinoma
Videos
Katrina Pedersen, MD, MS, Provides an Overview of Small Bowel Adenocarcinoma
12/15/2020
Dr Pedersen discusses the history of small bowel adenocarcinoma, and phase 2 research informing the evolving treatment landscape for this disease.
Dr Pedersen discusses the history of small bowel adenocarcinoma, and phase 2 research informing the evolving treatment landscape for this disease.
Dr Pedersen discusses the...
12/15/2020
Oncology
Katrina Pedersen, MD, Discusses Findings of the RAPIDO Trial for Locally Advanced Rectal Cancer
Videos
Katrina Pedersen, MD, Discusses Findings of the RAPIDO Trial for Locally Advanced Rectal Cancer
11/20/2020
Dr Pedersen talks about how short-course neoadjuvant chemotherapy improved outcomes over standard treatment in patients with locally advanced rectal cancer in the phase 3 RAPIDO trial.
Dr Pedersen talks about how short-course neoadjuvant chemotherapy improved outcomes over standard treatment in patients with locally advanced rectal cancer in the phase 3 RAPIDO trial.
Dr Pedersen talks about how...
11/20/2020
Oncology
Eileen O'Reilly, MD, on New Developments in Biliary Cancer Treatment
Videos
Eileen O'Reilly, MD, on New Developments in Biliary Cancer Treatment
11/16/2020
Eileen M O'Reilly, MD, highlights the treatment landscape of biliary cancer and new developments in 2020.
Eileen M O'Reilly, MD, highlights the treatment landscape of biliary cancer and new developments in 2020.
Eileen M O'Reilly, MD,...
11/16/2020
Oncology
Rachna Shroff, MD, Discusses Novel and Targeted Therapies in Biliary Cancer
Videos
Rachna Shroff, MD, Discusses Novel and Targeted Therapies in Biliary Cancer
10/23/2020
Dr Shroff highlights novel and targeted biliary cancer therapies at the virtual 2020 Great Debates & Updates in GI Malignancies meeting.
Dr Shroff highlights novel and targeted biliary cancer therapies at the virtual 2020 Great Debates & Updates in GI Malignancies meeting.
Dr Shroff highlights novel and...
10/23/2020
Oncology
Gabriela Chiorean, MD, Discusses Takeaways from SWOG1505 Trial in Pancreatic Cancer
Videos
Gabriela Chiorean, MD, Discusses Takeaways from SWOG1505 Trial in Pancreatic Cancer
10/08/2020
Dr Chiorean shares takeaways of the SWOG 1505 trial which did not determine perioperative modified FOLFIRINOX was superior to gemcitabine plus nab-paclitaxel in resectable pancreatic cancer.
Dr Chiorean shares takeaways of the SWOG 1505 trial which did not determine perioperative modified FOLFIRINOX was superior to gemcitabine plus nab-paclitaxel in resectable pancreatic cancer.
Dr Chiorean shares takeaways of...
10/08/2020
Oncology
Robert Nagourney, MD, Talks CRC Treated With FOLFOX or CAPOX
Podcasts
Robert Nagourney, MD, Talks CRC Treated With FOLFOX or CAPOX
10/07/2020
Robert Nagourney, MD, discusses the use of FOLFOX or CAPOX for oxaliplatin-resistant CRC.
Robert Nagourney, MD, discusses the use of FOLFOX or CAPOX for oxaliplatin-resistant CRC.
Robert Nagourney, MD, discusses...
10/07/2020
Oncology
Veena Shankaran, MD, MS, Discusses Financial Hardships in Patients With Metastatic CRC
Podcasts
Veena Shankaran, MD, MS, Discusses Financial Hardships in Patients With Metastatic CRC
09/20/2020
Dr Shankaran, discusses a study assessing financial toxicity in patients with metastatic CRC, and the upcoming expansion of the trial.
Dr Shankaran, discusses a study assessing financial toxicity in patients with metastatic CRC, and the upcoming expansion of the trial.
Dr Shankaran, discusses a study...
09/20/2020
Oncology
The Evolving Treatment Landscape of GIST and NETs
Videos
The Evolving Treatment Landscape of GIST and NETs
07/31/2020
Sharlene Gill, MD, MPH, FACP, FRCPC, highlights significant research data on developments in the treatment of GIST and NETs.
Sharlene Gill, MD, MPH, FACP, FRCPC, highlights significant research data on developments in the treatment of GIST and NETs.
Sharlene Gill, MD, MPH, FACP,...
07/31/2020
Oncology

Advertisement

Advertisement

Advertisement

Section Editor

Ghassan Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center, New York

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement